Can the life span of human marrow stromal cells be prolonged by bmi‐1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation?
The Journal of Gene Medicine2004Vol. 6(8), pp. 833–845
Citations Over TimeTop 10% of 2004 papers
Yukiji Takeda, Taisuke Mori, Hideaki Imabayashi, Tohru Kiyono, Satoshi Gojo, Shunichirou Miyoshi, Naoko Hida, Makoto Ita, Kaoru Segawa, Satoshi Ogawa, Michiie Sakamoto, Shinobu Nakamura, Akihiro Umezawa
Abstract
The life span of hMSCs was prolonged without interfering with cardiomyogenic differentiation. hMSCs with an extended life span can be used to produce a good experimental model of cardiac cell transplantation and may serve as a highly useful cell source for cardiomyocytic transplantation.
Related Papers
- → Telomere maintenance and cancer ? look, no telomerase(2002)147 cited
- → Telomere Length Dynamics in Telomerase-Positive Immortal Human Cell Populations(1998)105 cited
- Immortalized cells with no detectable telomerase activity. A review.(1997)
- → Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway(2001)90 cited
- [Relationship between telomere length and clinical and biological characteristics of the cancers with telomerase reactivation].(1998)